Abstract
Summary
Global Drug Discovery Services Market is valued approximately USD 17.9 billion in 2024 and is anticipated to grow with a healthy growth rate of more than 14.9% over the forecast period 2025-2032. Drug discovery services encompass a range of scientific and technological solutions provided by specialized organizations to support the identification, development, and optimization of new drug candidates. These services involve various stages of the drug discovery process, including target identification and validation, high-throughput screening, hit-to-lead optimization, medicinal chemistry, ADME (absorption, distribution, metabolism, and excretion) studies, and preclinical development. Through a combination of expertise, advanced technologies, and research methodologies, drug discovery services aim to accelerate the discovery and development of safe and effective drugs, ultimately advancing healthcare and addressing unmet medical needs. The market drivers boosting the market growth are increasing R&D expenditure and growing prevalence of chronic diseases.
According to Statista, in 2024, the total spending on pharmaceutical R&D accounted to USD 238 billion and is expected to amount to USD 285 billion in 2030. The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a significant need for innovative and effective drug therapies. According to Statista, the cancer deaths worldwide are projected to rise from nearly 10 million in 2024 to over 16 million by 2040. Moreover, expansion of Biologics and Cell-Based therapies and increasing demand for personalized medicines may create lucrative opportunities. However, the high cost of Drug Discovery and limited availability of skilled workforce stifles market growth throughout the forecast period of 2025-2032.
The key regions considered for the Global Drug Discovery Services Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2024 owing to a well-established pharmaceutical sector, ongoing research and development projects, significant R&D spending, expansion of the biosimilar and generics markets, and increasing outsourcing of R&D services by pharmaceutical and biopharmaceutical companies in the region. However, Asia Pacific is expected to become the fastest growing during the forecast period, owing to factors such as growing pharmaceutical industry, and increasing outsourcing drug discovery activities to specialized service providers to streamline operations, reduce costs, and access specialized expertise.
Major market player included in this report are:
Laboratory Corporation of America Holdings
Charles River Laboratories International, Inc.
Eurofins Scientific SE
GVK Biosciences Private Limited
Albany Molecular Research Inc. (AMRI)
Domainex Ltd.
GenScript Biotech Corporation
Aurigene Discovery Technologies Ltd.
WuXi AppTec
Evotec SE
Recent Developments in the Market:
In February 2025, Evotec SE and Related Sciences have extended their collaborative partnership to pursue an integrated multi-target drug discovery agreement. Their joint objective is to identify, research, and advance highly targeted therapies to address unmet medical requirements.
In January 2025, Charles River Laboratories completed the acquisition of SAMDI Tech, Inc., a provider of label-free high-throughput screening (HTS) solutions for drug discovery research. This acquisition enhances Charles River Laboratories' capabilities in label-free HTS MS platforms and expands its portfolio of drug discovery solutions, resulting in a comprehensive library of offerings.
Global Drug Discovery Services Market Report Scope:
Historical Data – 2022 - 2023
Base Year for Estimation – 2024
Forecast period - 2025-2032
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Process, Type, Drug Type, Therapeutic Area, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Process:
Target Selection
Target Validation
Hit-to-Lead Identification
Lead Optimization
Candidate Validation
By Type:
Chemistry Services
Biology Services
By Drug Type:
Small-Molecule Drugs
Biologics
By Therapeutic Area:
Oncology
Infectious Diseases
Neurological Diseases
Immunological Diseases
Endocrine and Metabolic Diseases
Respiratory Diseases
Digestive System Diseases
Cardiovascular Diseases
Genitourinary Diseases
Other Therapeutic Area
By End User:
Pharmaceutical & Biotechnology Companies
Academic Institutes
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Table of Contents
1 Executive Summary
1.1 Market Snapshot
1.2 Global & Segmental Market Estimates & Forecasts, 2022-2032 (USD Billion)
1.2.1 Drug Discovery Services Market, by Region, 2022-2032 (USD Billion)
1.2.2 Drug Discovery Services Market, by Process, 2022-2032 (USD Billion)
1.2.3 Drug Discovery Services Market, by Type, 2022-2032 (USD Billion)
1.2.4 Drug Discovery Services Market, by Drug Type, 2022-2032 (USD Billion)
1.2.5 Drug Discovery Services Market, by Therapeutic Area, 2022-2032 (USD Billion)
1.2.6 Drug Discovery Services Market, by End User, 2022-2032 (USD Billion)
1.3 Key Trends
1.4 Estimation Methodology
1.5 Research Assumption
2 Global Drug Discovery Services Market Definition and Scope
2.1 Objective of the Study
2.2 Market Definition & Scope
2.2.1 Industry Evolution
2.2.2 Scope of the Study
2.3 Years Considered for the Study
2.4 Currency Conversion Rates
3 Global Drug Discovery Services Market Dynamics
3.1 Drug Discovery Services Market Impact Analysis (2022-2032)
3.1.1 Market Drivers
- 3.1.1.1 Increasing R&D expenditure
- 3.1.1.2 Growing prevalence of chronic diseases
3.1.2 Market Challenges
- 3.1.2.1 High Cost of Drug Discovery
- 3.1.2.2 Limited availability of skilled workforce
3.1.3 Market Opportunities
- 3.1.3.1 Expansion of Biologics and Cell-Based Therapies
- 3.1.3.2 Increasing demand for personalized medicine
4 Global Drug Discovery Services Market Industry Analysis
4.1 Porter’s 5 Force Model
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Buyers
4.1.3 Threat of New Entrants
4.1.4 Threat of Substitutes
4.1.5 Competitive Rivalry
4.2 Porter’s 5 Force Impact Analysis
4.3 PEST Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Environmental
4.3.6 Legal
4.4 Top investment opportunity
4.5 Top winning strategies
4.6 COVID-19 Impact Analysis
4.7 Disruptive Trends
4.8 Industry Expert Perspective
4.9 Analyst Recommendation & Conclusion
5 Global Drug Discovery Services Market, by Process
5.1 Market Snapshot
5.2 Global Drug Discovery Services Market by Process, Performance - Potential Analysis
5.3 Global Drug Discovery Services Market Estimates & Forecasts by Process 2022-2032 (USD Billion)
5.4 Drug Discovery Services Market, Sub Segment Analysis
5.4.1 Target Selection
5.4.2 Target Validation
5.4.3 Hit-to-Lead Identification
5.4.4 Lead Optimization
5.4.5 Candidate Validation
6 Global Drug Discovery Services Market, by Type
6.1 Market Snapshot
6.2 Global Drug Discovery Services Market by Type, Performance - Potential Analysis
6.3 Global Drug Discovery Services Market Estimates & Forecasts by Type 2022-2032 (USD Billion)
6.4 Drug Discovery Services Market, Sub Segment Analysis
6.4.1 Chemistry Services
6.4.2 Biology Services
7 Global Drug Discovery Services Market, by Drug Type
7.1 Market Snapshot
7.2 Global Drug Discovery Services Market by Drug Type, Performance - Potential Analysis
7.3 Global Drug Discovery Services Market Estimates & Forecasts by Drug Type 2022-2032 (USD Billion)
7.4 Drug Discovery Services Market, Sub Segment Analysis
7.4.1 Small-Molecule Drugs
7.4.2 Biologics
8 Global Drug Discovery Services Market, by Therapeutic Area
8.1 Market Snapshot
8.2 Global Drug Discovery Services Market by Therapeutic Area, Performance - Potential Analysis
8.3 Global Drug Discovery Services Market Estimates & Forecasts by Therapeutic Area 2022-2032 (USD Billion)
8.4 Drug Discovery Services Market, Sub Segment Analysis
8.4.1 Oncology
8.4.2 Infectious Diseases
8.4.3 Neurological Diseases
8.4.4 Immunological Diseases
8.4.5 Endocrine and Metabolic Diseases
8.4.6 Respiratory Diseases
8.4.7 Digestive System Diseases
8.4.8 Cardiovascular Diseases
8.4.9 Genitourinary Diseases
8.4.10 Other Therapeutic Area
9 Global Drug Discovery Services Market, by End User
9.1 Market Snapshot
9.2 Global Drug Discovery Services Market by End User, Performance - Potential Analysis
9.3 Global Drug Discovery Services Market Estimates & Forecasts by End User 2022-2032 (USD Billion)
9.4 Drug Discovery Services Market, Sub Segment Analysis
9.4.1 Pharmaceutical & Biotechnology Companies
9.4.2 Academic Institutes
9.4.3 Other End Users
10 Global Drug Discovery Services Market, Regional Analysis
10.1 Top Leading Countries
10.2 Top Emerging Countries
10.3 Drug Discovery Services Market, Regional Market Snapshot
10.4 North America Drug Discovery Services Market
10.4.1 U.S. Drug Discovery Services Market
- 10.4.1.1 Process breakdown estimates & forecasts, 2022-2032
- 10.4.1.2 Type breakdown estimates & forecasts, 2022-2032
- 10.4.1.3 Drug Type breakdown estimates & forecasts, 2022-2032
- 10.4.1.4 Therapeutic Area breakdown estimates & forecasts, 2022-2032
- 10.4.1.5 End User breakdown estimates & forecasts, 2022-2032
10.4.2 Canada Drug Discovery Services Market
10.5 Europe Drug Discovery Services Market Snapshot
10.5.1 U.K. Drug Discovery Services Market
10.5.2 Germany Drug Discovery Services Market
10.5.3 France Drug Discovery Services Market
10.5.4 Spain Drug Discovery Services Market
10.5.5 Italy Drug Discovery Services Market
10.5.6 Rest of Europe Drug Discovery Services Market
10.6 Asia-Pacific Drug Discovery Services Market Snapshot
10.6.1 China Drug Discovery Services Market
10.6.2 India Drug Discovery Services Market
10.6.3 Japan Drug Discovery Services Market
10.6.4 Australia Drug Discovery Services Market
10.6.5 South Korea Drug Discovery Services Market
10.6.6 Rest of Asia Pacific Drug Discovery Services Market
10.7 Latin America Drug Discovery Services Market Snapshot
10.7.1 Brazil Drug Discovery Services Market
10.7.2 Mexico Drug Discovery Services Market
10.8 Middle East & Africa Drug Discovery Services Market
10.8.1 Saudi Arabia Drug Discovery Services Market
10.8.2 South Africa Drug Discovery Services Market
10.8.3 Rest of Middle East & Africa Drug Discovery Services Market
11 Competitive Intelligence
11.1 Key Company SWOT Analysis
11.1.1 Company 1
11.1.2 Company 2
11.1.3 Company 3
11.2 Top Market Strategies
11.3 Company Profiles
11.3.1 Laboratory Corporation of America Holdings
- 11.3.1.1 Key Information
- 11.3.1.2 Overview
- 11.3.1.3 Financial (Subject to Data Availability)
- 11.3.1.4 Product Summary
- 11.3.1.5 Recent Developments
11.3.2 Charles River Laboratories International, Inc
11.3.3 Eurofins Scientific SE
11.3.4 GVK Biosciences Private Limited
11.3.5 Albany Molecular Research Inc. (AMRI)
11.3.6 Domainex Ltd
11.3.7 GenScript Biotech Corporation
11.3.8 Aurigene Discovery Technologies Ltd
11.3.9 WuXi AppTec
11.3.10 Evotec SE
12 Research Process
12.1 Research Process
12.1.1 Data Mining
12.1.2 Analysis
12.1.3 Market Estimation
12.1.4 Validation
12.1.5 Publishing
12.2 Research Attributes
12.3 Research Assumption